Altay Therapeutics is Biotechnology in United States that focus on immune activation business. Founded in 2019. They cover business area such as developer, small molecule therapy, disease-cause dna-bind protein, chronic liver disease, matrix deposition, immune activation, primarily affect tissue, clinician, chronic indication, rheumatoid arthritis, fibrotic disease, ulcerative colitis, liver cancer.
2019
( 5 years old in 2024 )
Immune Activation
-
455 Mission Bay
Boulevard South
San Francisco, CA 94158
United States
Private
developersmall molecule therapydisease-cause dna-bind proteinchronic liver diseasematrix depositionimmune activationprimarily affect tissueclinicianchronic indicationrheumatoid arthritisfibrotic diseaseulcerative colitisliver cancer
* We use standard office opening hours in near Altay Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Altay Therapeutics is Biotechnology business from United States that founded in 2019 (5 years old in 2024), Altay Therapeutics business is focusing on Immune Activation.
Altay Therapeutics headquarter office and corporate office address is located in 455 Mission Bay Boulevard South San Francisco, CA 94158 United States.
Altay Therapeutics was founded in United States.
In 2024, Altay Therapeutics is currently focus on immune activation sector.
Above is snippet of Google Trends for "immune activation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Altay Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
